Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
Timo Minssen is Professor of Law specializing in legal aspects of biomedical innovation at the University of Copenhagen (UCPH). He is the Managing Director and Founder of UCPH's new Center for Advanced Studies and the Collaborative Research Programme in Biomedical Innovation Law (CeBIL). He is also an LML Research Affiliate at the University of Cambridge, and Inter-CeBIL Research Affiliate at the Petrie-Flom Centre for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. As part-time Senior Advisor at the law firm X-officio Advokat AB, he specialises in supporting research infrastructures and their business partners in legal & governance matters.
Previously, Timo had been Professor of Biotechnology Law at UCPH's Centre for Information & Innovation Law (CIIR), Visiting Research Fellow and Guest Professor at the Technical University of Munich (TUM), the Universities of Cambridge and Oxford (UK), Harvard Law School and at the Chicago-Kent College of Law (US), as well as Max Planck stipendiate at the Max Planck Institute for Innovation & Competition in Munich (Germany). Moreover, he was trained in the German Court system (Referendariat) and worked for shorter periods at the European Patent Office (EPO), leading law firms, tech start-ups and for an interdisciplinary epigenetics project as a fellow of the Swedish Pufendorf Institute for Advanced Studies.
Timo holds a German law degree (Staatsexamen) from Georg-August-University in Göttingen, as well as Swedish biotech & IPR related LL.M., LL.Lic., and LL.D. degrees from Lund University and Uppsala University. His PhD thesis delivered a comprehensive study on the patentability of biopharmaceutical technology in the US & Europe, which received the Swedish King Oscar award. He has also received the Awapatent and Jorcks Foundation research prizes and was a finalist of the Swedish Wallenberg Academy Fellows program.
Education & Visiting Scholarships
2024 | TUM Global Visiting Professor, Technical University of Munich (Germany) |
2016 | Visiting Research Fellow, University of Cambridge (UK) |
2014 | Visiting Research Fellow, University of Oxford (UK). |
2013-14 | Visiting Scholar, Harvard Law School (US). |
2012 | LL.D. - Doctor of Laws (Swedish "juris doktor"), EU/US patent law, Lund University, Sweden. |
2007 | Visiting Scholar with course responsibility, Chicago-Kent College of Law, US. |
2005-07 | Max Planck Stipendiate, Max Planck Institute for Intellectual Property-, Competition-, and Tax Law, Munich, Germany. |
2005 | LL.Lic. - Licentiate of Laws, Studies in Molecular Biology & Russian, Lund University, Sweden |
2003 | M.I.C.L. - Master of International and Comparative Law, Uppsala University, Sweden |
2002-03 | Ref. iur. - "Referendariat", Department of Public Prosecution & District Court, Lübeck, Germany. |
2002 | LL.M. - Master of European Affairs & Suffolk University (US) Summer School, Lund University, Sweden. |
2001 | Juristisches "Staatsexamen" & Dipl. Jur., University of Göttingen, Germany. |
Employment
2018- | Professor of Law, Director of CeBIL, UCPH, Denmark. |
2016-17 | Professor of Biotechnology Law, UCPH, Denmark. |
2013-16 | Assoc. Professor of IP & Innovation Law, UCPH, Denmark. |
2009-13 | Ass. Professor in Intellectual Property Law, University of Copenhagen (UCPH), Denmark. |
2009 | Research fellow, Pufendorf Institute for Advanced Studies (Epigenetics group), Lund University, Sweden. |
2008-09 |
Adjunct lecturer in EU-, Competition-, Market- & Intellectual Property Law, Lund University & Växjö University (now Linné University), Sweden. |
2007 | Guest-Professor and course director, Chicago-Kent College of Law, USA. |
2003-08 |
PhD stipendiate in Civil Law, Faculty of Law, Lund University, Sweden. |
2002-03 | Rechtsreferendar, State of Schleswig Holstein, Germany. |
Part-time employment, internships etc.
2019- |
Senior Advisor, X-officio, Law firm |
2006-09 |
Legal counsel in the life science sector, Magle AB, Sweden. |
2007 | European Patent Office, Munich, Germany. |
2002 | Counsel, camPoint AG, Wiesbaden, Germany. |
2001 | Mannheimer Swartling, Berlin, Germany. |
2000 | Satorius AG, Göttingen, Germany. |
1999 | Lagerlöf & Leman (now Linklaters), Stockholm, Sweden. |
1998 | Landahl & Wistrand (now Wistrand), Gothenburg, Sweden. |
1997 | Müller, Loebell & Ludewig, Jever, Germany. |
1996 | District Court (Jever) & Department for Agriculture (Göttingen), Germany. |
Sprogkundskaber
- German (native)
- English (full professional skills)
- Swedish (full professional skills)
- Danish (limited professional skills)
- Norwegian (limited skills)
- Russian (basic)
- French (most basic EU certificate)
- Advanced Latin Proficiency Certificate ("Grosses Latinum")
Uddannelse
Jur. Dr.
ID: 16150437
Flest downloads
-
4348
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
2242
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
2097
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet